15 articles for NC Ray
The following articles (labelled with PubMed ID or TBD) are for your review
PMID
Data
Article Title
Organization
Discovery of a novel non-steroidal GR antagonist with in vivo efficacy in the olanzapine-induced weight gain model in the rat.

Corcept Therapeutics
1H-Pyrazolo[3,4-g]hexahydro-isoquinolines as selective glucocorticoid receptor antagonists with high functional activity.

Corcept Therapeutics
2-Benzenesulfonyl-8a-benzyl-hexahydro-2H-isoquinolin-6-ones as selective glucocorticoid receptor antagonists.

Corcept Therapeutics
Discovery and optimization of novel, non-steroidal glucocorticoid receptor modulators.

Argenta Discovery
Novel 7-methoxy-6-oxazol-5-yl-2,3-dihydro-1H-quinazolin-4-ones as IMPDH inhibitors.

Ucb Pharma
Quinazolinethiones and quinazolinediones, novel inhibitors of inosine monophosphate dehydrogenase: synthesis and initial structure-activity relationships.

Celltech R and D
GDC-9545 (Giredestrant): A Potent and Orally Bioavailable Selective Estrogen Receptor Antagonist and Degrader with an Exceptional Preclinical Profile for ER+ Breast Cancer.

Genentech
Discovery of a class of highly potent Janus Kinase 1/2 (JAK1/2) inhibitors demonstrating effective cell-based blockade of IL-13 signaling.

Genentech
Discovery of a C-8 hydroxychromene as a potent degrader of estrogen receptor alpha with improved rat oral exposure over GDC-0927.

Genentech
MELANOCORTIN 4 RECEPTOR ANTAGONISTS AND USES THEREOF

Pfizer
TRICYCLIC COMPOUND, AND PREPARATION METHOD THEREFOR AND USE THEREOF

Shanghaitech University
Kinase inhibitors

Topivert Pharma
Urease inhibitors from Hypericum oblongifolium WALL.

University of Peshawar
In silico binding analysis and SAR elucidations of newly designed benzopyrazine analogs as potent inhibitors of thymidine phosphorylase.

Universiti Teknologi Mara (Uitm)
Pyrazolopyrimidine JAK inhibitor compounds and methods

Genentech